Nobilis Health Corp.
NRTSF
$0.00
$0.000.00%
06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
---|---|---|---|---|---|
Net Income | -71.65% | -74.01% | -41.12% | -77.16% | -89.56% |
Total Depreciation and Amortization | 73.09% | 60.40% | 31.37% | 25.22% | 22.69% |
Total Amortization of Deferred Charges | -2.50% | -13.06% | -29.01% | 782.76% | 809.85% |
Total Other Non-Cash Items | 16.00% | 158.91% | 216.42% | 159.56% | 154.87% |
Change in Net Operating Assets | -37.00% | -94.32% | 51.14% | 0.58% | 8.11% |
Cash from Operations | -16.96% | -3.81% | 1,622.02% | 78.50% | 45.83% |
Capital Expenditure | 56.96% | 61.70% | -3.70% | -62.42% | -55.00% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -116.48% | -116.48% | -261.20% | -718.52% | -460.88% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | 100.00% | 100.00% |
Cash from Investing | -75.22% | -75.36% | -192.67% | -305.72% | -231.59% |
Total Debt Issued | -28.97% | -35.35% | -35.49% | 357.72% | 1,156.20% |
Total Debt Repaid | 80.73% | 80.37% | 85.45% | -279.32% | -627.28% |
Issuance of Common Stock | -- | -- | -- | -88.75% | -82.21% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -136.25% | -27.06% | 20.68% | 53.90% | 54.55% |
Cash from Financing | 12.44% | 6.63% | 27.52% | 601.66% | 353.08% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -222.02% | -153.05% | -122.86% | 1,082.08% | 180.98% |